$1.4898
-0.0702[-4.50%]
At close: May 10
$1.4898
0[0.00%]
After Hours: 6:02PM EDT
Immuneering
(NASDAQ:IMRX)Immuneering Stock (NASDAQ:IMRX), Quotes and News Summary
Immuneering Stock (NASDAQ: IMRX) stock price, news, charts, stock research, profile.
| Open | $1.590 |
| Close | $1.450 |
| Volume / Avg. | 252.267K / 763.345K |
| Day Range | 1.400 - 1.590 |
| 52 Wk Range | 1.380 - 11.920 |
| Market Cap | $44.178M |
| P/E Ratio | - |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 32 |
| Short Interest | 12.37% |
| Days to Cover | 3.94 |
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Immuneering (IMRX) stock?
You can purchase shares of Immuneering (NASDAQ: IMRX) through any online brokerage.
Who are Immuneering's (IMRX) competitors?
Other companies in Immuneering’s space includes: Gain Therapeutics (NASDAQ:GANX), Intensity Therapeutics (NASDAQ:INTS), Bolt Biotherapeutics (NASDAQ:BOLT), Sensei Biotherapeutics (NASDAQ:SNSE) and BioLine Rx (NASDAQ:BLRX).
What is the target price for Immuneering (IMRX) stock?
The latest price target for Immuneering (NASDAQ: IMRX) was reported by Needham on Wednesday, May 8, 2024. The analyst firm set a price target for 15.00 expecting IMRX to rise to within 12 months (a possible 906.85% upside). 17 analyst firms have reported ratings in the last year.
Current Stock Price for Immuneering (IMRX)?
The stock price for Immuneering (NASDAQ: IMRX) is $1.4898 last updated May 10, 2024 at 6:02 PM EDT.
Does Immuneering (IMRX) pay a dividend?
There are no upcoming dividends for Immuneering.
When is Immuneering (NASDAQ:IMRX) reporting earnings?
Immuneering’s Q2 earnings are confirmed for Thursday, August 1, 2024.
Is Immuneering (IMRX) going to split?
There is no upcoming split for Immuneering.
What sector and industry does Immuneering (IMRX) operate in?
Immuneering is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.